Sometimes the parts are worth more than the whole. That’s the case with Exor, whose massive discount has created a low-risk bet for value-seeking investors.
HILLSBORO, Ore., February 17, 2026--(BUSINESS WIRE)--Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced a Cyber Resilience Reference Kit designed to help ...
Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced a Cyber Resilience Reference Kit designed to help industrial and edge device manufacturers accelerate secure ...
MILAN, Feb 16 (Reuters) - Exor, the Agnelli family's investment vehicle, and the founder of Lifenet Healthcare have agreed to sell the Italian private clinics and diagnostics group to insurer Reale ...
MILAN, Feb 16 (Reuters) - Exor (EXOR.AS), opens new tab, the Agnelli family's investment vehicle, and the founder of Lifenet Healthcare have agreed to sell the Italian private clinics and diagnostics ...
Analysts cut 2025 and 2026 EPS estimates after Stellantis skipped a 2025 payout, but they still kept a Buy rating and a €124 target. This stings more than it used to because Exor is now an “investment ...
Feb 6 (Reuters) - Stellantis (STLAM.MI), opens new tab shares tumbled on Friday after the carmaker booked charges of around 22.2 billion euros ($26.5 billion) in the second half of 2025, related to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results